South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

lagamed -

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

xellia pharmaceutical aps, denmark - doxycycline - syrup - 10 mg/ml

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

xellia pharmaceutical aps, denmark - doxycycline - tablet - 100 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

pharmacare limited û woodmead - tablet - see ingredients - each tablet contains doxycycline hydrochloride equivalent to 100 mg doxycycline

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

pharmacare limited û woodmead - capsules - see ingredients - each capsule contains doxycycline hydrochloride equivalent to 50 mg doxycycline

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع ادوية رضا جردانة - reda jardaneh drug store - doxycycline 100 mg - 100 mg

Namibia - English - Namibia Medicines Regulatory Council

aspen pharmacare - doxycycline hcl - capsules - doxycycline hcl capsules 50mg

Namibia - English - Namibia Medicines Regulatory Council

pharmacare limited - doxycycline hcl equivalent to doxycycline 100 mg - tablet - each tablet contains ; doxycycline hcl equivalent to doxycycline 100 mg

United States - English - NLM (National Library of Medicine)

precision dose inc. - digoxin (unii: 73k4184t59) (digoxin - unii:73k4184t59) - digoxin 0.05 mg in 1 ml - digoxin oral solution, usp is indicated for the treatment of mild to moderate heart failure. digoxin increases left ventricular ejection fraction and improves heart failure symptoms as evidenced by increased exercise capacity and decreased heart failure-related hospitalizations and emergency care, while having no effect on mortality. where possible, digoxin should be used with a diuretic and an angiotensin-converting enzyme inhibitor, but an optimal order for starting these three drugs cannot be specified. digoxin increases myocardial contractility in pediatric patients with heart failure. digoxin oral solution, usp is indicated for the control of resting ventricular response rate in patients with chronic atrial fibrillation. digoxin should not be used for the treatment of multifocal atrial tachycardia. allergy to digoxin is rare. digoxin is contraindicated in patients with a known hypersensitivity to digoxin or other forms of digitalis. digitalis glycosides, such as digoxin, are contraindicated in ventricula

United States - English - NLM (National Library of Medicine)

american health packaging - digoxin (unii: 73k4184t59) (digoxin - unii:73k4184t59) - digoxin 125 ug - digoxin tablets, usp are indicated for the treatment of mild to moderate heart failure in adults. digoxin tablets, usp increase left ventricular ejection fraction and improve heart failure symptoms as evidenced by improved exercise capacity and decreased heart failure-related hospitalizations and emergency care, while having no effect on mortality. where possible, digoxin tablets, usp should be used in combination with a diuretic and an angiotensin-converting enzyme (ace) inhibitor. digoxin tablets, usp increase myocardial contractility in pediatric patients with heart failure. digoxin tablets, usp are indicated for the control of ventricular response rate in adult patients with chronic atrial fibrillation. digoxin tablets are contraindicated in patients with: - ventricular fibrillation [see warnings and precautions (5.1)] - known hypersensitivity to digoxin (reactions seen include unexplained rash, swelling of the mouth, lips or throat or a difficulty in breathing). a hypersensitivity reaction to ot